CMG Chipotle Mexican Grill | $3,116.02
+6.5% | 4/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $3,250.00 -> $3,350.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
HCP HashiCorp | $32.82
+4.5% | 4/24/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 4/24/2024 |
LFMD LifeMD | $10.82
-3.0% | 4/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $14.00 | Low | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 4/23/2024 |
WGS GeneDx | $11.17
-5.5% | 4/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $15.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 4/22/2024 |
PINE Alpine Income Property Trust | $14.96
-0.7% | 4/22/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of Alpine Income Property Trust (NYSE:PINE) on 4/22/2024 |
ISRG Intuitive Surgical | $373.12
-0.5% | 4/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $412.00 -> $421.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 4/19/2024 |
|
DMTK DermTech | $0.59
-4.9% | 4/19/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of DermTech (NASDAQ:DMTK) on 4/19/2024 |
FVRR Fiverr International | $20.05
-2.0% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 4/18/2024 |
EFC Ellington Financial | $11.61
+0.4% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.50 -> $13.50 | Low | View details for BTIG Research rating of Ellington Financial (NYSE:EFC) on 4/18/2024 |
FIP FTAI Infrastructure | $7.41
-0.4% | 4/18/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 4/18/2024 |
CGEM Cullinan Oncology | $19.25
+1.9% | 4/17/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Cullinan Oncology (NASDAQ:CGEM) on 4/17/2024 |
BXMT Blackstone Mortgage Trust | $17.65
-3.3% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $22.00 | N/A | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 4/17/2024 |
FBRT Franklin BSP Realty Trust | $12.57
-0.2% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.00 -> $14.00 | N/A | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 4/17/2024 |
RC Ready Capital | $8.70
-1.4% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $12.00 -> $10.00 | N/A | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 4/17/2024 |
STWD Starwood Property Trust | $19.12
-1.5% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $23.00 | N/A | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 4/17/2024 |
XNCR Xencor | $19.23
+1.1% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $56.00 -> $38.00 | Low | View details for BTIG Research rating of Xencor (NASDAQ:XNCR) on 4/16/2024 |
DHI D.R. Horton | $144.20
-1.3% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $174.00 -> $169.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 4/16/2024 |
HAFN Hafnia | $7.55
-0.4% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of Hafnia (NYSE:HAFN) on 4/12/2024 |
TBPH Theravance Biopharma | $9.14
-0.3% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Theravance Biopharma (NASDAQ:TBPH) on 4/12/2024 |
CARM Carisma Therapeutics | $1.64
-2.4% | 4/11/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 4/11/2024 |
RCEL AVITA Medical | $8.30
-3.2% | 4/11/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of AVITA Medical (NASDAQ:RCEL) on 4/11/2024 |
DCGO DocGo | $3.49
-0.9% | 4/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $13.00 -> $11.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 4/10/2024 |
APP AppLovin | $69.21
-0.7% | 4/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $87.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 4/9/2024 |
OM Outset Medical | $2.38
-6.7% | 4/8/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Outset Medical (NASDAQ:OM) on 4/8/2024 |
MSTR MicroStrategy | $1,240.41
-2.0% | 4/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $780.00 -> $1,800.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 4/5/2024 |
ADPT Adaptive Biotechnologies | $2.61
+0.4% | 4/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 4/4/2024 |
RVLV Revolve Group | $19.43
-1.9% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $24.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 4/3/2024 |
KEX Kirby | $112.10
+10.9% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Kirby (NYSE:KEX) on 4/3/2024 |
SHCR Sharecare | $0.74
-3.9% | 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sharecare (NASDAQ:SHCR) on 4/1/2024 |
PIII P3 Health Partners | $0.48
-4.0% | 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of P3 Health Partners (NASDAQ:PIII) on 4/1/2024 |
CMG Chipotle Mexican Grill | $3,116.02
+6.5% | 3/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2,750.00 -> $3,250.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 3/28/2024 |
CYBR CyberArk Software | $245.07
+0.2% | 3/28/2024 | Initiated by | BTIG Research | - | Buy | $317.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 3/28/2024 |
OTLK Outlook Therapeutics | $8.19
-0.1% | 3/27/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $50.00 | Low | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/27/2024 |
VKTX Viking Therapeutics | $68.86
+5.8% | 3/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $125.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
NUVB Nuvation Bio | $2.63
-1.5% | 3/26/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $5.00 | Low | View details for BTIG Research rating of Nuvation Bio (NYSE:NUVB) on 3/26/2024 |
MASI Masimo | $135.24
-0.5% | 3/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $145.00 -> $166.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 3/25/2024 |
PZZA Papa John's International | $62.91
-2.3% | 3/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Papa John’s International (NASDAQ:PZZA) on 3/22/2024 |
SFL SFL | $13.14
+0.8% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of SFL (NYSE:SFL) on 3/20/2024 |
HQY HealthEquity | $79.04
-0.2% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $110.00 | Low | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 3/20/2024 |
JANX Janux Therapeutics | $47.10
-2.3% | 3/21/2024 | Initiated by | BTIG Research | - | Buy | $62.00 | Low | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 3/21/2024 |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
USFD US Foods | $50.42
-0.7% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $52.00 -> $62.00 | Low | View details for BTIG Research rating of US Foods (NYSE:USFD) on 3/19/2024 |
CLSK CleanSpark | $19.54
-1.2% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $22.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 3/19/2024 |
TDW Tidewater | $93.23
+0.6% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $110.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 3/19/2024 |
MXCT MaxCyte | $3.69
-1.3% | 3/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 3/13/2024 |
SHAK Shake Shack | $101.35
+1.8% | 3/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $120.00 | Low | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 3/14/2024 |
LFMD LifeMD | $10.82
-3.0% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 3/15/2024 |
VKTX Viking Therapeutics | $68.86
+5.8% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $86.00 -> $100.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
GMED Globus Medical | $50.35
-2.1% | 3/18/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $60.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 3/18/2024 |
HLTH Cue Health | $0.15
| 3/14/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Cue Health (NASDAQ:HLTH) on 3/14/2024 |
BTDR Bitdeer Technologies Group | $6.46
-0.3% | 3/13/2024 | Initiated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/13/2024 |
TKNO Alpha Teknova | $1.72
+0.6% | 3/12/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Alpha Teknova (NASDAQ:TKNO) on 3/12/2024 |
IDYA IDEAYA Biosciences | $38.62
-3.1% | 3/8/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of IDEAYA Biosciences (NASDAQ:IDYA) on 3/8/2024 |
GNL Global Net Lease | $6.93
-0.6% | 3/8/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Global Net Lease (NYSE:GNL) on 3/8/2024 |
ZLDPF Zealand Pharma A/S | $86.17
-1.2% | 3/7/2024 | Initiated by | BTIG Research | - | Buy | | Low | View details for BTIG Research rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 3/7/2024 |
SOPH SOPHiA GENETICS | $4.95
-2.2% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of SOPHiA GENETICS (NASDAQ:SOPH) on 3/6/2024 |
CRWD CrowdStrike | $298.02
+0.1% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $322.00 -> $432.00 | N/A | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
HCP HashiCorp | $32.82
+4.5% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $25.00 -> $27.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
MGNX MacroGenics | $14.37
-8.5% | 3/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $24.00 | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 3/4/2024 |
COMP Compass | $3.22
-3.3% | 2/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.50 -> $4.30 | Low | View details for BTIG Research rating of Compass (NYSE:COMP) on 2/29/2024 |
MRSN Mersana Therapeutics | $2.85
-1.0% | 2/29/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
BMBL Bumble | $10.55
+1.1% | 2/28/2024 | Target Lowered by | BTIG Research | - | Buy | $20.00 -> $15.00 | Low | View details for BTIG Research rating of Bumble (NASDAQ:BMBL) on 2/28/2024 |
ANAB AnaptysBio | $18.87
-2.1% | 2/26/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 2/26/2024 |
TTD Trade Desk | $83.34
-0.5% | 2/23/2024 | Target Raised by | BTIG Research | - | Buy | $91.00 -> $98.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 2/23/2024 |
PLL Piedmont Lithium | $11.42
+2.8% | 2/23/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Piedmont Lithium (NASDAQ:PLL) on 2/23/2024 |
ETSY Etsy | $67.20
+0.5% | 2/22/2024 | Target Lowered by | BTIG Research | - | Buy | $90.00 -> $87.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
UBER Uber Technologies | $69.31
-0.1% | 2/22/2024 | Target Raised by | BTIG Research | - | Buy | $80.00 -> $90.00 | Low | View details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 2/22/2024 |
FLYX flyExclusive | $4.11
-8.7% | 2/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 2/22/2024 |
GHLD Guild | $13.50
| 2/21/2024 | Initiated by | BTIG Research | - | Buy | $18.00 | Low | View details for BTIG Research rating of Guild (NYSE:GHLD) on 2/21/2024 |
CBAY CymaBay Therapeutics | $32.48
| 2/13/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of CymaBay Therapeutics (NASDAQ:CBAY) on 2/13/2024 |
IQV IQVIA | $234.08
-2.8% | 2/13/2024 | Initiated by | BTIG Research | - | Buy | $285.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 2/13/2024 |
PYXS Pyxis Oncology | $4.30
-3.4% | 2/9/2024 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of Pyxis Oncology (NASDAQ:PYXS) on 2/9/2024 |
CMG Chipotle Mexican Grill | $3,116.02
+6.5% | 2/7/2024 | Target Raised by | BTIG Research | - | Buy | $2,650.00 -> $2,750.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024 |
PCTY Paylocity | $156.58
+0.3% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $200.00 | Low | View details for BTIG Research rating of Paylocity (NASDAQ:PCTY) on 2/6/2024 |
PYCR Paycor HCM | $17.62
+1.0% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $26.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 2/6/2024 |
PAYC Paycom Software | $186.58
-0.7% | 2/6/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Paycom Software (NYSE:PAYC) on 2/6/2024 |
MCD McDonald's | $275.60
-0.4% | 2/6/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 2/6/2024 |
BOOT Boot Barn | $107.28
-0.1% | 2/1/2024 | Target Lowered by | BTIG Research | - | Buy | $102.00 -> $100.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 2/1/2024 |
SBUX Starbucks | $87.84
-1.0% | 1/31/2024 | Target Lowered by | BTIG Research | - | Buy | $125.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 1/31/2024 |
SQ Block | $72.80
-1.7% | 1/30/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $85.00 | Low | View details for BTIG Research rating of Block (NYSE:SQ) on 1/30/2024 |
PNST Pinstripes | $3.16
+2.9% | 1/29/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 1/29/2024 |
CCSI Consensus Cloud Solutions | $12.47
-1.0% | 1/26/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 1/26/2024 |
BE Bloom Energy | $9.56
-0.8% | 1/25/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 1/25/2024 |
MDAI Spectral AI | $1.84
-0.5% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Spectral AI (NASDAQ:MDAI) on 1/23/2024 |
FLYX flyExclusive | $4.11
-8.7% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $9.00 | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 1/23/2024 |
S SentinelOne | $21.21
-1.7% | 1/22/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 1/22/2024 |
MTTR Matterport | $4.68
+0.9% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Matterport (NASDAQ:MTTR) on 1/19/2024 |
SMRT SmartRent | $2.33
-1.7% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $4.50 | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 1/19/2024 |
CSGP CoStar Group | $90.34
-1.8% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of CoStar Group (NASDAQ:CSGP) on 1/19/2024 |
APPF AppFolio | $216.65
+0.3% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $215.00 | Low | View details for BTIG Research rating of AppFolio (NASDAQ:APPF) on 1/19/2024 |
PSFE Paysafe | $14.50
-0.8% | 1/17/2024 | Initiated by | BTIG Research | - | Buy | $19.00 | Low | View details for BTIG Research rating of Paysafe (NYSE:PSFE) on 1/17/2024 |
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad) Don't Buy Bullion or Mining Stocks. Do THIS Instead
As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. |
MARA Marathon Digital | $19.01
-0.4% | 1/17/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $27.00 | Low | View details for BTIG Research rating of Marathon Digital (NASDAQ:MARA) on 1/17/2024 |
ACRS Aclaris Therapeutics | $1.19
+1.7% | 1/11/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/11/2024 |
BIIB Biogen | $202.46
+0.2% | 1/7/2024 | Reiterated by | BTIG Research | Analyst T. Shrader | Neutral | | Low | View details for BTIG Research rating of Biogen (NASDAQ:BIIB) on 1/7/2024 |
PYPL PayPal | $64.10
-1.1% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 1/5/2024 |
GOGL Golden Ocean Group | $13.82
+1.7% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Golden Ocean Group (NASDAQ:GOGL) on 1/5/2024 |
GNK Genco Shipping & Trading | $21.23
+0.0% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Genco Shipping & Trading (NYSE:GNK) on 1/5/2024 |
EGLE Eagle Bulk Shipping | $62.60
| 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Eagle Bulk Shipping (NASDAQ:EGLE) on 1/5/2024 |
CMG Chipotle Mexican Grill | $3,116.02
+6.5% | 1/4/2024 | Target Raised by | BTIG Research | - | Buy | $2,175.00 -> $2,650.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 1/4/2024 |
NTRA Natera | $91.28
-0.2% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $85.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 12/29/2023 |
NEO NeoGenomics | $13.85
-1.3% | 12/29/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $25.00 -> $21.00 | Low | View details for BTIG Research rating of NeoGenomics (NASDAQ:NEO) on 12/29/2023 |
HPP Hudson Pacific Properties | $5.67
-4.7% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 12/29/2023 |
BSX Boston Scientific | $73.30
+0.5% | 12/29/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 12/29/2023 |
LSPD Lightspeed Commerce | $13.22
-2.7% | 12/28/2023 | Target Raised by | BTIG Research | - | Buy | $20.00 -> $24.00 | Low | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 12/28/2023 |
ORGO Organogenesis | $2.29
-23.2% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $4.00 -> $6.00 | Low | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 12/27/2023 |
EXPE Expedia Group | $136.25
+0.3% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023 |
OVID Ovid Therapeutics | $2.99
-5.1% | 12/21/2023 | Initiated by | BTIG Research | - | Buy | $11.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 12/21/2023 |
SYRE Spyre Therapeutics | $32.47
-1.6% | 12/20/2023 | Initiated by | BTIG Research | - | Buy | $32.00 | Low | View details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/20/2023 |
APGE Apogee Therapeutics | $45.86
-1.5% | 12/20/2023 | Initiated by | BTIG Research | - | Buy | $43.00 | Low | View details for BTIG Research rating of Apogee Therapeutics (NASDAQ:APGE) on 12/20/2023 |
OPEN Opendoor Technologies | $2.07
-3.7% | 12/20/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Opendoor Technologies (NASDAQ:OPEN) on 12/20/2023 |
EXEL Exelixis | $23.53
-0.8% | 12/19/2023 | Initiated by | BTIG Research | - | Buy | $27.00 | Low | View details for BTIG Research rating of Exelixis (NASDAQ:EXEL) on 12/19/2023 |
TRIP Tripadvisor | $26.24
+0.3% | 12/14/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $25.00 | Low | View details for BTIG Research rating of Tripadvisor (NASDAQ:TRIP) on 12/14/2023 |
VEL Velocity Financial | $16.93
+0.4% | 12/12/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $17.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 12/12/2023 |
CLSK CleanSpark | $19.54
-1.2% | 12/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 -> $12.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 12/11/2023 |
MSTR MicroStrategy | $1,240.41
-2.0% | 12/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $560.00 -> $690.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 12/11/2023 |
HCP HashiCorp | $32.82
+4.5% | 12/8/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $33.00 -> $25.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 12/8/2023 |
AURA Aura Biosciences | $7.08
-0.3% | 12/8/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $38.00 -> $21.00 | Low | View details for BTIG Research rating of Aura Biosciences (NASDAQ:AURA) on 12/8/2023 |
DECK Deckers Outdoor | $807.12
-5.2% | 12/7/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $650.00 -> $800.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 12/7/2023 |
BRZE Braze | $41.18
-0.4% | 12/7/2023 | Target Raised by | BTIG Research | - | Buy | $60.00 -> $75.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 12/7/2023 |
CXM Sprinklr | $11.84
-1.2% | 12/7/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sprinklr (NYSE:CXM) on 12/7/2023 |
AVDX AvidXchange | $11.83
-0.3% | 12/6/2023 | Initiated by | BTIG Research | - | Buy | $14.00 | Low | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/6/2023 |
XTNT Xtant Medical | $0.90
+1.1% | 12/5/2023 | Initiated by | BTIG Research | - | Buy | $2.00 | N/A | View details for BTIG Research rating of Xtant Medical (NYSEAMERICAN:XTNT) on 12/5/2023 |
RWT Redwood Trust | $5.67
-1.6% | 12/5/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $8.50 | Low | View details for BTIG Research rating of Redwood Trust (NYSE:RWT) on 12/5/2023 |
STC Stewart Information Services | $61.68
-2.0% | 12/4/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $70.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 12/4/2023 |
AKBA Akebia Therapeutics | $1.33
-2.9% | 11/29/2023 | Reiterated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Akebia Therapeutics (NASDAQ:AKBA) on 11/29/2023 |
CRWD CrowdStrike | $298.02
+0.1% | 11/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $192.00 -> $239.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 11/27/2023 |
ZS Zscaler | $174.81
-1.5% | 11/22/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $191.00 -> $229.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/22/2023 |
NTST NETSTREIT | $17.02
-0.8% | 11/22/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of NETSTREIT (NYSE:NTST) on 11/22/2023 |
VSTM Verastem | $9.22
-1.1% | 11/21/2023 | Reiterated by | BTIG Research | - | Buy | $27.00 | Low | View details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 11/21/2023 |
OXM Oxford Industries | $105.75
-1.4% | 11/21/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Oxford Industries (NYSE:OXM) on 11/21/2023 |
FL Foot Locker | $21.92
-4.2% | 11/21/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Foot Locker (NYSE:FL) on 11/21/2023 |
GPN Global Payments | $124.63
-2.2% | 11/20/2023 | Initiated by | BTIG Research | - | Buy | $135.00 | Low | View details for BTIG Research rating of Global Payments (NYSE:GPN) on 11/20/2023 |
WKHS Workhorse Group | $0.16
| 11/15/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Workhorse Group (NASDAQ:WKHS) on 11/15/2023 |
GP GreenPower Motor | $1.84
-2.6% | 11/15/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of GreenPower Motor (NASDAQ:GP) on 11/15/2023 |
NOTE FiscalNote | $1.27
+5.8% | 11/15/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of FiscalNote (NYSE:NOTE) on 11/15/2023 |
RBOT Vicarious Surgical | $0.26
-3.7% | 11/14/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Vicarious Surgical (NYSE:RBOT) on 11/14/2023 |
GTLB GitLab | $56.01
-0.7% | 11/13/2023 | Initiated by | BTIG Research | - | Buy | $56.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 11/13/2023 |
VUZI Vuzix | $1.34
| 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Vuzix (NASDAQ:VUZI) on 11/10/2023 |
MODN Model N | $29.63
-0.1% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Model N (NYSE:MODN) on 11/10/2023 |
FREY FREYR Battery | $1.57
+1.3% | 11/10/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 11/10/2023 |
LVLU Lulu's Fashion Lounge | $1.13
-0.9% | 11/9/2023 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Lulu’s Fashion Lounge (NASDAQ:LVLU) on 11/9/2023 |
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad) Don't Buy Bullion or Mining Stocks. Do THIS Instead
As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. |
DNA Ginkgo Bioworks | $0.78
-8.2% | 11/9/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 11/9/2023 |
OMCL Omnicell | $27.13
-1.1% | 11/3/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Omnicell (NASDAQ:OMCL) on 11/3/2023 |
DECK Deckers Outdoor | $807.12
-5.2% | 10/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $640.00 -> $650.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 10/27/2023 |
SHYF The Shyft Group | $11.23
+4.6% | 10/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of The Shyft Group (NASDAQ:SHYF) on 10/27/2023 |
HR Healthcare Realty Trust | $14.04
-2.4% | 10/24/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $17.00 | Low | View details for BTIG Research rating of Healthcare Realty Trust (NYSE:HR) on 10/24/2023 |
SKLZ Skillz | $6.23
-1.0% | 10/23/2023 | Upgraded by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of Skillz (NYSE:SKLZ) on 10/23/2023 |
VEL Velocity Financial | $16.93
+0.4% | 10/23/2023 | Initiated by | BTIG Research | - | Buy | $14.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 10/23/2023 |
IVR Invesco Mortgage Capital | $8.42
-2.2% | 10/20/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Invesco Mortgage Capital (NYSE:IVR) on 10/20/2023 |
GMAB Genmab A/S | $27.46
-3.5% | 10/13/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $44.00 -> $46.00 | Low | View details for BTIG Research rating of Genmab A/S (NASDAQ:GMAB) on 10/13/2023 |
MTNB Matinas BioPharma | $0.18
| 10/11/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $3.00 | N/A | View details for BTIG Research rating of Matinas BioPharma (NYSEAMERICAN:MTNB) on 10/11/2023 |
WRBY Warby Parker | $12.75
-2.5% | 10/12/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $17.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 10/12/2023 |
LYRA Lyra Therapeutics | $5.17
-1.1% | 10/6/2023 | Reiterated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Lyra Therapeutics (NASDAQ:LYRA) on 10/6/2023 |
ETSY Etsy | $67.20
+0.5% | 10/6/2023 | Target Lowered by | BTIG Research | - | | $108.00 -> $90.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 10/6/2023 |
UWMC UWM | $6.40
-2.6% | 10/5/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of UWM (NYSE:UWMC) on 10/5/2023 |
KIDS OrthoPediatrics | $29.94
-4.0% | 10/3/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $59.00 -> $52.00 | Low | View details for BTIG Research rating of OrthoPediatrics (NASDAQ:KIDS) on 10/3/2023 |
PMN ProMIS Neurosciences | $1.95
| 10/2/2023 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of ProMIS Neurosciences (NASDAQ:PMN) on 10/2/2023 |
MCD McDonald's | $275.60
-0.4% | 10/2/2023 | Target Lowered by | BTIG Research | - | | $315.00 -> $300.00 | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 10/2/2023 |
RBLX Roblox | $35.52
+1.6% | 10/2/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $54.00 -> $52.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 10/2/2023 |
LGIH LGI Homes | $94.88
-1.0% | 10/2/2023 | Upgraded by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of LGI Homes (NASDAQ:LGIH) on 10/2/2023 |
INSW International Seaways | $54.58
+1.9% | 9/28/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $45.00 -> $55.00 | Low | View details for BTIG Research rating of International Seaways (NYSE:INSW) on 9/28/2023 |
FLYW Flywire | $20.55
-2.7% | 9/28/2023 | Initiated by | BTIG Research | - | Buy | $37.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 9/28/2023 |
TRUE TrueCar | $2.80
-3.8% | 9/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 9/27/2023 |
SPLK Splunk | $156.90
| 9/26/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Splunk (NASDAQ:SPLK) on 9/26/2023 |
LYFT Lyft | $16.07
-1.7% | 9/26/2023 | Reiterated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Lyft (NASDAQ:LYFT) on 9/26/2023 |
APP AppLovin | $69.21
-0.7% | 9/26/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $40.00 -> $46.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 9/26/2023 |
HPP Hudson Pacific Properties | $5.67
-4.7% | 9/26/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $11.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 9/26/2023 |
CSR Centerspace | $64.36
-0.8% | 9/25/2023 | Reiterated by | BTIG Research | - | Buy | $69.00 | Low | View details for BTIG Research rating of Centerspace (NYSE:CSR) on 9/25/2023 |
MORF Morphic | $27.98
+1.0% | 9/25/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Morphic (NASDAQ:MORF) on 9/25/2023 |
CART Maplebear | $34.54
+0.8% | 9/22/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Maplebear (NASDAQ:CART) on 9/22/2023 |
BSX Boston Scientific | $73.30
+0.5% | 9/21/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $62.00 -> $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 9/21/2023 |
TDW Tidewater | $93.23
+0.6% | 9/20/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $91.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 9/20/2023 |
HLX Helix Energy Solutions Group | $11.30
+2.6% | 9/20/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $17.00 | Low | View details for BTIG Research rating of Helix Energy Solutions Group (NYSE:HLX) on 9/20/2023 |
FTI TechnipFMC | $26.63
+3.5% | 9/20/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $23.00 -> $28.00 | Low | View details for BTIG Research rating of TechnipFMC (NYSE:FTI) on 9/20/2023 |
DCGO DocGo | $3.49
-0.9% | 9/19/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.00 -> $13.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 9/19/2023 |
SHOO Steven Madden | $39.72
-1.8% | 9/19/2023 | Reiterated by | BTIG Research | - | Buy | $40.00 | Low | View details for BTIG Research rating of Steven Madden (NASDAQ:SHOO) on 9/19/2023 |
LEN Lennar | $152.79
-0.9% | 9/18/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $148.00 -> $161.00 | Low | View details for BTIG Research rating of Lennar (NYSE:LEN) on 9/18/2023 |
GNL Global Net Lease | $6.93
-0.6% | 9/18/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $19.00 -> $15.00 | Low | View details for BTIG Research rating of Global Net Lease (NYSE:GNL) on 9/18/2023 |
CIFR Cipher Mining | $4.43
-4.5% | 9/15/2023 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Cipher Mining (NASDAQ:CIFR) on 9/15/2023 |
PANW Palo Alto Networks | $288.79
-1.7% | 9/13/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $270.00 -> $292.00 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 9/13/2023 |
OFIX Orthofix Medical | $13.10
-3.4% | 9/12/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Orthofix Medical (NASDAQ:OFIX) on 9/12/2023 |
BRZE Braze | $41.18
-0.4% | 9/8/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $50.00 -> $54.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 9/8/2023 |
CBAY CymaBay Therapeutics | $32.48
| 9/8/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $24.00 | Low | View details for BTIG Research rating of CymaBay Therapeutics (NASDAQ:CBAY) on 9/8/2023 |
ZS Zscaler | $174.81
-1.5% | 9/6/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $185.00 -> $191.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 9/6/2023 |
PIII P3 Health Partners | $0.48
-4.0% | 8/31/2023 | Initiated by | BTIG Research | - | Buy | $5.00 | Low | View details for BTIG Research rating of P3 Health Partners (NASDAQ:PIII) on 8/31/2023 |
CRWD CrowdStrike | $298.02
+0.1% | 8/31/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $188.00 -> $192.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 8/31/2023 |
BRZE Braze | $41.18
-0.4% | 8/31/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $43.00 -> $50.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 8/31/2023 |
OTLK Outlook Therapeutics | $8.19
-0.1% | 8/30/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/30/2023 |
TMCI Treace Medical Concepts | $10.30
-3.5% | 8/28/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $32.00 -> $27.50 | Low | View details for BTIG Research rating of Treace Medical Concepts (NASDAQ:TMCI) on 8/28/2023 |
ZBH Zimmer Biomet | $119.75
-1.2% | 8/28/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $139.00 | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 8/28/2023 |
UPWK Upwork | $11.18
-1.6% | 8/28/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 8/28/2023 |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
SPLK Splunk | $156.90
| 8/24/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $128.00 -> $137.00 | Low | View details for BTIG Research rating of Splunk (NASDAQ:SPLK) on 8/24/2023 |
GMAB Genmab A/S | $27.46
-3.5% | 8/24/2023 | Initiated by | BTIG Research | - | Buy | | Low | View details for BTIG Research rating of Genmab A/S (NASDAQ:GMAB) on 8/24/2023 |
RCUS Arcus Biosciences | $14.73
-4.5% | 8/23/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $70.00 | Low | View details for BTIG Research rating of Arcus Biosciences (NYSE:RCUS) on 8/23/2023 |
PANW Palo Alto Networks | $288.79
-1.7% | 8/21/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $259.00 -> $270.00 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/21/2023 |
DCGO DocGo | $3.49
-0.9% | 8/18/2023 | Initiated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 8/18/2023 |
FL Foot Locker | $21.92
-4.2% | 8/17/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $42.00 -> $35.00 | Low | View details for BTIG Research rating of Foot Locker (NYSE:FL) on 8/17/2023 |
JKHY Jack Henry & Associates | $165.89
+0.4% | 8/17/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $200.00 -> $173.00 | Low | View details for BTIG Research rating of Jack Henry & Associates (NASDAQ:JKHY) on 8/17/2023 |
BFI BurgerFi International | $0.39
-2.5% | 8/17/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for BTIG Research rating of BurgerFi International (NASDAQ:BFI) on 8/17/2023 |
INVH Invitation Homes | $34.48
+0.5% | 8/17/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Invitation Homes (NYSE:INVH) on 8/17/2023 |
TLIS Talis Biomedical | $8.89
-3.4% | 8/16/2023 | Target Raised by | BTIG Research | - | Sell -> Sell | $5.00 | Low | View details for BTIG Research rating of Talis Biomedical (NASDAQ:TLIS) on 8/16/2023 |
MQ Marqeta | $5.36
-2.7% | 8/16/2023 | Downgraded by | BTIG Research | - | Neutral -> Sell | $4.00 | Low | View details for BTIG Research rating of Marqeta (NASDAQ:MQ) on 8/16/2023 |
DCTH Delcath Systems | $5.26
-3.5% | 8/15/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $20.00 | Low | View details for BTIG Research rating of Delcath Systems (NASDAQ:DCTH) on 8/15/2023 |
MYPS PLAYSTUDIOS | $2.21
-0.9% | 8/14/2023 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of PLAYSTUDIOS (NASDAQ:MYPS) on 8/14/2023 |
IMCR Immunocore | $58.00
-0.8% | 8/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $85.00 -> $91.00 | Low | View details for BTIG Research rating of Immunocore (NASDAQ:IMCR) on 8/11/2023 |
CBAY CymaBay Therapeutics | $32.48
| 8/11/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $22.00 | Low | View details for BTIG Research rating of CymaBay Therapeutics (NASDAQ:CBAY) on 8/11/2023 |
APP AppLovin | $69.21
-0.7% | 8/10/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $34.00 -> $40.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 8/10/2023 |
BNGO Bionano Genomics | $0.76
| 8/10/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 | Low | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 8/10/2023 |
ACET Adicet Bio | $1.81
-3.2% | 8/10/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $20.00 -> $10.00 | Low | View details for BTIG Research rating of Adicet Bio (NASDAQ:ACET) on 8/10/2023 |
ORGO Organogenesis | $2.29
-23.2% | 8/10/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $10.00 -> $4.00 | Low | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 8/10/2023 |
CYRX Cryoport | $16.03
-1.2% | 8/10/2023 | Target Lowered by | BTIG Research | - | | $33.00 -> $28.00 | N/A | View details for BTIG Research rating of Cryoport (NASDAQ:CYRX) on 8/10/2023 |
FNF Fidelity National Financial | $49.88
-1.5% | 8/9/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $47.00 -> $48.00 | Low | View details for BTIG Research rating of Fidelity National Financial (NYSE:FNF) on 8/9/2023 |
UPST Upstart | $22.83
-1.3% | 8/9/2023 | Target Lowered by | BTIG Research | - | | $72.00 -> $64.00 | Low | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 8/9/2023 |
BL BlackLine | $58.89
-1.7% | 8/9/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $80.00 -> $70.00 | Low | View details for BTIG Research rating of BlackLine (NASDAQ:BL) on 8/9/2023 |
PANW Palo Alto Networks | $288.79
-1.7% | 8/9/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $307.00 -> $259.00 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/9/2023 |
AKYA Akoya Biosciences | $3.82
+0.3% | 8/8/2023 | Target Lowered by | BTIG Research | - | | $14.00 -> $11.00 | Low | View details for BTIG Research rating of Akoya Biosciences (NASDAQ:AKYA) on 8/8/2023 |
VCEL Vericel | $45.45
-1.4% | 8/8/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $39.00 | Low | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 8/8/2023 |
DMTK DermTech | $0.59
-4.9% | 8/7/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for BTIG Research rating of DermTech (NASDAQ:DMTK) on 8/7/2023 |
SPT Sprout Social | $51.36
-2.1% | 8/6/2023 | Target Lowered by | BTIG Research | - | | $76.00 -> $70.00 | Low | View details for BTIG Research rating of Sprout Social (NASDAQ:SPT) on 8/6/2023 |
ESNT Essent Group | $53.86
-0.6% | 8/4/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $50.00 -> $55.00 | Low | View details for BTIG Research rating of Essent Group (NYSE:ESNT) on 8/4/2023 |
DKNG DraftKings | $41.09
+0.6% | 8/4/2023 | Target Raised by | BTIG Research | - | | $34.00 -> $39.00 | Low | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 8/4/2023 |
PZZA Papa John's International | $62.91
-2.3% | 8/4/2023 | Target Lowered by | BTIG Research | - | | $100.00 -> $95.00 | Low | View details for BTIG Research rating of Papa John’s International (NASDAQ:PZZA) on 8/4/2023 |
FVRR Fiverr International | $20.05
-2.0% | 8/3/2023 | Target Raised by | BTIG Research | - | Buy | $40.00 -> $44.00 | Low | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 8/3/2023 |
QTWO Q2 | $52.89
-1.7% | 8/3/2023 | Target Raised by | BTIG Research | - | | $36.00 -> $42.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/3/2023 |
BOOT Boot Barn | $107.28
-0.1% | 8/3/2023 | Target Raised by | BTIG Research | - | | $98.00 -> $115.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 8/3/2023 |
GKOS Glaukos | $100.11
-0.8% | 8/3/2023 | Target Raised by | BTIG Research | - | | $83.00 -> $86.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 8/3/2023 |
LGIH LGI Homes | $94.88
-1.0% | 8/2/2023 | Target Raised by | BTIG Research | - | | $77.00 -> $103.00 | Low | View details for BTIG Research rating of LGI Homes (NASDAQ:LGIH) on 8/2/2023 |
PEN Penumbra | $205.50
-0.3% | 8/2/2023 | Target Lowered by | BTIG Research | - | | $351.00 -> $308.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 8/2/2023 |
MTCH Match Group | $31.69
-0.8% | 8/2/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $60.00 | Low | View details for BTIG Research rating of Match Group (NASDAQ:MTCH) on 8/2/2023 |
MLNK MeridianLink | $17.39
-1.5% | 8/2/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of MeridianLink (NYSE:MLNK) on 8/2/2023 |
UBER Uber Technologies | $69.31
-0.1% | 8/1/2023 | Target Raised by | BTIG Research | - | Buy | $55.00 -> $60.00 | Low | View details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 8/1/2023 |
DT Dynatrace | $46.61
-0.3% | 8/1/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $57.00 -> $65.00 | Low | View details for BTIG Research rating of Dynatrace (NYSE:DT) on 8/1/2023 |
SOFI SoFi Technologies | $7.59
-0.1% | 7/31/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $14.00 -> $13.00 | Low | View details for BTIG Research rating of SoFi Technologies (NASDAQ:SOFI) on 7/31/2023 |
ONON ON | $31.92
-1.4% | 7/31/2023 | Initiated by | BTIG Research | - | Sell -> Neutral | | Low | View details for BTIG Research rating of ON (NYSE:ONON) on 7/31/2023 |
RIG Transocean | $5.75
-0.5% | 7/28/2023 | Target Raised by | BTIG Research | - | Buy | $10.00 -> $12.00 | Low | View details for BTIG Research rating of Transocean (NYSE:RIG) on 7/28/2023 |
DTIL Precision BioSciences | $9.72
-1.0% | 7/28/2023 | Target Lowered by | BTIG Research | - | Buy | $180.00 -> $60.00 | Low | View details for BTIG Research rating of Precision BioSciences (NASDAQ:DTIL) on 7/28/2023 |
DECK Deckers Outdoor | $807.12
-5.2% | 7/28/2023 | Target Raised by | BTIG Research | - | Buy | $613.00 -> $640.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 7/28/2023 |
TTD Trade Desk | $83.34
-0.5% | 7/28/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $103.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 7/28/2023 |
MRSN Mersana Therapeutics | $2.85
-1.0% | 7/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Mersana Therapeutics (NASDAQ:MRSN) on 7/27/2023 |
TPIC TPI Composites | $2.39
-3.2% | 7/27/2023 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of TPI Composites (NASDAQ:TPIC) on 7/27/2023 |
EGP EastGroup Properties | $155.66
-1.5% | 7/26/2023 | Target Raised by | BTIG Research | - | | $198.00 -> $218.00 | Low | View details for BTIG Research rating of EastGroup Properties (NYSE:EGP) on 7/26/2023 |
ATRC AtriCure | $22.61
-1.9% | 7/26/2023 | Target Raised by | BTIG Research | - | | $56.00 -> $68.00 | Low | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 7/26/2023 |
PHM PulteGroup | $111.36
-0.8% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $83.00 -> $100.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 7/25/2023 |
PYPL PayPal | $64.10
-1.1% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $85.00 -> $90.00 | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 7/25/2023 |
OPRT Oportun Financial | $3.10
-4.3% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $7.00 -> $7.50 | Low | View details for BTIG Research rating of Oportun Financial (NASDAQ:OPRT) on 7/25/2023 |
JKHY Jack Henry & Associates | $165.89
+0.4% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $183.00 -> $200.00 | Low | View details for BTIG Research rating of Jack Henry & Associates (NASDAQ:JKHY) on 7/25/2023 |
UPST Upstart | $22.83
-1.3% | 7/25/2023 | Target Raised by | BTIG Research | - | Buy | $42.00 -> $72.00 | Low | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 7/25/2023 |
ZS Zscaler | $174.81
-1.5% | 7/25/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $185.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 7/25/2023 |
PROK ProKidney | $2.71
| 7/24/2023 | Initiated by | BTIG Research | - | Buy | $16.00 | Low | View details for BTIG Research rating of ProKidney (NASDAQ:PROK) on 7/24/2023 |
LADR Ladder Capital | $10.80
+2.9% | 7/24/2023 | Target Raised by | BTIG Research | - | Buy | $10.00 -> $12.50 | Low | View details for BTIG Research rating of Ladder Capital (NYSE:LADR) on 7/24/2023 |
APP AppLovin | $69.21
-0.7% | 7/24/2023 | Upgraded by | BTIG Research | - | Neutral -> Buy | $34.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 7/24/2023 |
